These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 2362794)

  • 61. Efficacy and toxicity profiles of two chemoradiotherapies for stage II laryngeal cancer - a comparison between late course accelerated hyperfractionation (LCAHF) and conventional fractionation (CF).
    Okazaki E; Matsushita N; Tashiro M; Shimatani Y; Ishii K; Hosono M; Oishi M; Teranishi Y; Iguchi H; Miki Y
    Acta Otolaryngol; 2017 Aug; 137(8):883-887. PubMed ID: 28301268
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Repopulation during radical radiotherapy for T1 glottic cancer.
    Saarilahti K; Kajanti M; Lehtonen H; Hämäläinen T; Joensuu H
    Radiother Oncol; 1998 May; 47(2):155-9. PubMed ID: 9683363
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Supraglottic versus glottic laryngeal cancer: epidemiological and pathological aspects.
    Silvestri F; Bussani R; Stanta G; Cosatti C; Ferlito A
    ORL J Otorhinolaryngol Relat Spec; 1992; 54(1):43-8. PubMed ID: 1584591
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Pre-operative short intensive radiation therapy of T3-T4 laryngeal carcinoma.
    Kazem I; van der Broek P; Brinkman W; Turek M; Bosboom BJ
    Acta Radiol Ther Phys Biol; 1975 Dec; 14(6):522-8. PubMed ID: 1224993
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [Is gender a prognostic factor in early stages of laryngeal cancer treated by radiotherapy?].
    Walasek T; Dymek P; Kowalska T; Reinfuss M
    Otolaryngol Pol; 1997; 51(2):139-42. PubMed ID: 9518324
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Twice-a-day radiation therapy for supraglottic carcinoma.
    Wang CC; Suit HD; Blitzer PH
    Int J Radiat Oncol Biol Phys; 1986 Jan; 12(1):3-7. PubMed ID: 3943989
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Dose, fractionation and overall treatment time in radiation therapy--the effects on local control for cancer of the larynx.
    van Putten WL; van der Sangen MJ; Hoekstra CJ; Levendag PC
    Radiother Oncol; 1994 Feb; 30(2):97-108. PubMed ID: 8184125
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Radiotherapy for laryngeal cancer-technical aspects and alternate fractionation.
    Yamazaki H; Suzuki G; Nakamura S; Yoshida K; Konishi K; Teshima T; Ogawa K
    J Radiat Res; 2017 Jul; 58(4):495-508. PubMed ID: 28898958
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [[Radical radiotherapy in patients with laryngeal cancer in clinical material of Institute Oncology in Gliwice treated in year 1990-1996].
    Mucha A; Składowski K; Wygoda A; Sasiadek W; Goleń M; Przeorek W
    Otolaryngol Pol; 2000; 54 Suppl 31():40-4. PubMed ID: 10974840
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Clinical Outcomes of Radiotherapy for Stage 1 Glottic Carcinoma: Comparing Accelerated Hyperfractionation and Once-daily Fractionation.
    Endo M; Fukuda Y; Okada K; Ogawa K; Nakamura M; Takahashi S; Murakami E; Shibayama C; Kawahara M; Akahane K; Onaga R; Nagatomo T; Kanazawa T; Nishino H; Mori H; Shirai K
    In Vivo; 2023; 37(5):2320-2326. PubMed ID: 37652523
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Comparison of Three Fractionation Schedules in Radiotherapy for Early Glottic Squamous Cell Carcinoma.
    Suzuki G; Yamazaki H; Aibe N; Masui K; Shimizu D; Kimoto T; Nishimura T; Kawabata K; Nagasawa S; Machida K; Yoshino Y; Watanabe S; Sugiyama Y; Arai A; Hirano S; Yamada K
    In Vivo; 2020; 34(5):2769-2774. PubMed ID: 32871813
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Does prolonged treatment course adversely affect local control of carcinoma of the larynx?
    Wang CC; Efird JT
    Int J Radiat Oncol Biol Phys; 1994 Jul; 29(4):657-60. PubMed ID: 8040011
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Radiation treatment of laryngeal carcinoma with special reference to CRE values.
    Underskog I; Sorbe B; Persson JE
    Acta Radiol Oncol; 1985; 24(3):227-32. PubMed ID: 2994371
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Could Primary Chemoradiotherapy in T2 Glottic Cancers Yield Results Comparable to Primary Radiotherapy in T1? Considerations from 531 German Early Stage Patients.
    Dyckhoff G; Warta R; Herold-Mende C; Rudolph E; Plinkert PK; Ramroth H
    Cancers (Basel); 2021 Mar; 13(7):. PubMed ID: 33807125
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Gender influences subsite of origin of laryngeal carcinoma.
    Stephenson WT; Barnes DE; Holmes FF; Norris CW
    Arch Otolaryngol Head Neck Surg; 1991 Jul; 117(7):774-8. PubMed ID: 1863444
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Accelerated fractionation vs hyperfractionation: rationales for several treatments per day.
    Thames HD; Peters LJ; Withers HR; Fletcher GH
    Int J Radiat Oncol Biol Phys; 1983 Feb; 9(2):127-38. PubMed ID: 6833014
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Carotid dosimetry for T1 glottic cancer radiotherapy.
    Garcez K; Lim CC; Whitehurst P; Thomson D; Ho KF; Lowe M; Sykes A; Lee LW; Yap B; Slevin N
    Br J Radiol; 2014 Jun; 87(1038):20130754. PubMed ID: 24628251
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Outcomes of hypofractionation for early-stage glottic carcinoma.
    Uysal B; Gamsiz H; Colak O; Beyzadeoglu M
    J Cancer Res Ther; 2023 Oct; 19(7):1962-1966. PubMed ID: 38376304
    [TBL] [Abstract][Full Text] [Related]  

  • 79. The optimal radiotherapy schedule for T1 glottic cancers?
    Hendry JH; Slevin NJ
    Int J Radiat Oncol Biol Phys; 1999 Jul; 44(4):967-8. PubMed ID: 10386656
    [No Abstract]   [Full Text] [Related]  

  • 80. Dose-response relationship for supraglottic laryngeal carcinoma.
    Peters LJ; Thames HD
    Int J Radiat Oncol Biol Phys; 1983 Mar; 9(3):421-2. PubMed ID: 6841198
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.